HIV-1 MN #1929 represents a defined peptide segment from the MN strain envelope region, enabling controlled investigations of epitope organization. Its sequence supports studies of structural topology and receptor-associated binding characteristics. Researchers use it to explore conformational states that contribute to antigenic variability. The molecule is valuable for mapping interaction hotspots and analyzing folding behavior.
CAT No: H09821
1. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
2. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More